You may not have heard that Thompson Street Capital Partners acquired a little business called Alpaca Audiology in June 2017. Ever since, the add-ons have been coming fast and thick. As M&A in specialty physician practices goes, dentists and dermatologists are the hot targets in 2018. Every now and then we find a urology or […]
Irving Place Capital Management scored big in August — $1.74 billion big. The private equity firm sold Universal Hospital Services, a medical equipment management company, to Federal Street Acquisition Corp. (NASDAQ: FSAC), a special purpose acquisition company sponsored by an affiliate of Thomas H. Lee Partners. Universal Hospital’s diverse customer base includes over 4,000 acute […]
Specialty vaccine maker PaxVax Inc. has changed owners again, more than doubling its equity value in two and a half years. The Redwood City, Calfornia-based company was acquired by Cerberus Capital Management in December 2015 for $105 million from Ignition Growth Capital and other investors. The sellers retained a minority stake, while Cerberus took the […]
Retailers have been the big disruptors in the healthcare market in recent months, but not in digital health. CVS Health (NYSE: CVS) and Aetna‘s (NYSE: AET) merger, announced in December 2017, is still on track. Amazon‘s (NASDAQ: AMZN) deal for PillPack has many wondering what’s next in the online pharmaceutical space. Now there’s Best Buy […]
Pharmaceutical deal activity made a comeback in the second quarter of 2018, with 41 transactions reported, and counting. That is the highest quarterly haul in two years, but what happened to dealmaking in the intervening period? Deal volume dropped off soon after the 2016 presidential election, as companies and investors waited for President Trump’s promised […]
UnitedHealth Group is not taking much time off this summer, in what continues to be one of the most active healthcare M&A years on record. It recently announced the acquisition of Peoples Health, a Medicare Advantage plan based in Metairie, Louisiana, that has 63,000 members. Included in the acquisition were four clinics plus Capital City […]
After finishing up its strategic alternatives review, OvaScience, which is focused on developing treatments for infertility, decided the best way to go for shareholders was to merge into Millendo Therapeutics, a clinical-stage biopharmaceutical company focused on developing novel treatments for orphan endocrine diseases. OvaScience’s market cap was just $26 million, and it really hadn’t had […]
What happens when the FDA rejects not one drug application, but two, in a short period of time? Your share price plunges by nearly 90%. And then you look for options. Such was the dilemma faced by UK-based drug maker Vernalis plc. So, last March the Vernalis board started looking for offers to buy the […]
The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day. in the quarterly report. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in […]
July’s deal volume beat the totals posted in July 2017, but didn’t quite match those posted the previous month. The healthcare merger & acquisition market is still going strong, in other words. Not too hot, no sign of getting cold. Preliminary deal volume in July reached 124 transactions, a 10% loss compared with June’s busy […]
